Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.
PET-Technology, the national network of nuclear medicine centers established with the RUSNANO support, opened its 10th center in Samara. The investments in Samara center amounted to more than 410 million rubles.
Telix Pharmaceuticals, a biopharmaceutical company focused on the development of targeted radiopharmaceuticals or “molecularly-targeted radiation”, announced the establishment Telix Pharmaceuticals Japan
A center for personalized nuclear medicine was opened on the basis of the Ulyanovsk State University. The new center will ensure the development of technology for manufacturing the radiopharmaceuticals.
Abzena, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licence agreement with Telix Pharmaceuticals Limited
The researchers at Tomsk Polytechnic University (TPU), together with their colleagues from the Tomsk Research Institute of Oncology and the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, have developed a radiopharmaceutical labeled with Technetium-99 isotope